1. Gabaldon-Albero, Alba, Mayo, Sonia, Martinez, Francisco. 2024. NR4A2 as a Novel Target Gene for Developmental and Epileptic Encephalopathy: A Systematic Review of Related Disorders and Therapeutic Strategies. In International journal of molecular sciences, 25, . doi:10.3390/ijms25105198. https://pubmed.ncbi.nlm.nih.gov/38791237/
2. Li, Bo, Yang, Ziyi, Mao, Fei, Jin, Jie, Lu, Yan. 2023. Downregulation of microRNA-145a-5p promotes steatosis-to-NASH progression through upregulation of Nr4a2. In Journal of hepatology, 79, 1096-1109. doi:10.1016/j.jhep.2023.06.019. https://pubmed.ncbi.nlm.nih.gov/37463623/
3. He, Yong, Wang, Yue, Yu, Heming, Guo, Yi, Xie, Peng. 2023. Protective effect of Nr4a2 (Nurr1) against LPS-induced depressive-like behaviors via regulating activity of microglia and CamkII neurons in anterior cingulate cortex. In Pharmacological research, 191, 106717. doi:10.1016/j.phrs.2023.106717. https://pubmed.ncbi.nlm.nih.gov/36948326/
4. Song, Xiaotong, Sun, Ning, Zhang, Aixia, Yang, Chunxia, Zhang, Kerang. 2021. Association Between NR4A2 Gene Polymorphism and Depressive Symptoms and Antidepressant Effect. In Neuropsychiatric disease and treatment, 17, 2613-2623. doi:10.2147/NDT.S319548. https://pubmed.ncbi.nlm.nih.gov/34408421/
5. Ruiz-Sánchez, Elizabeth, Jiménez-Genchi, Janet, Alcántara-Flores, Yessica M, López-Navarro, María E, Rojas, Patricia. 2021. Working memory deficits in schizophrenia are associated with the rs34884856 variant and expression levels of the NR4A2 gene in a sample Mexican population: a case control study. In BMC psychiatry, 21, 86. doi:10.1186/s12888-021-03081-w. https://pubmed.ncbi.nlm.nih.gov/33563249/